Aspirin resistance.
Tantry
Udaya S
US
Sinai Center for Thrombosis Research, Baltimore, MD, USA.
Mahla
Elisabeth
E
Gurbel
Paul A
PA
D001241:Aspirin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D051545:Cyclooxygenase 1 / Q000187:drug effects / Q000502:physiology; D051546:Cyclooxygenase 2 / Q000187:drug effects / Q000502:physiology; D004351:Drug Resistance; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects / Q000502:physiology; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D013928:Thromboxane A2 / Q000378:metabolism; D013929:Thromboxane B2 / Q000378:metabolism
D010975:Platelet Aggregation Inhibitors; D013929:Thromboxane B2; D013928:Thromboxane A2; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D001241:Aspirin